Announcements

17 February 2025
MDPI Celebrates Excellence in Medical Research with Early Career Researcher Awards


MDPI, a pioneer in scholarly open access publishing, and the Lee Kong Chian School of Medicine (LKCMedicine), Singapore, proudly announce the successful conclusion of the first edition the MDPI Early Career Researcher Awards. The awards, which recognize outstanding contributions to medical and biomedical research, were presented to six exceptional researchers during an awards ceremony held at LKCMedicine HQ Building on 28 November 2024.

Honoring Excellence in Research

The awards recognize exceptional postdoctoral researchers and Ph.D. students who have demonstrated outstanding originality, innovation, and impact in their respective fields. We are honored to announce the winners of the 2024 edition:

Early Career Researcher (Postdoc) Award:

  • Dr. Theresia Handayani Mina, “Adiposity and Metabolic Health in Asian Populations: An Epidemiological Study Using Dual-Energy X-Ray Absorptiometry in Singapore”;
  • Dr. Erfan Rezvani Ghomi, “Wound Healing Improvement by Novel Aligned Antimicrobial Nanofibrous 3D Scaffolds”;
  • Dr. Yadollah Ranjbar Slamloo, “Functional Alterations of The Prefrontal Circuit Underlying Cognitive Aging in Mice”.

Early Career Researcher (Ph.D.) Award:

  • Pritisha Rozario, “Mechanistic Basis for Potassium Efflux-Driven Activation of the Human NLRP1 Inflammasome”;
  • Michelle Law Cheok Yien, “Chikungunya Virus Nonstructural Protein 1 is a Versatile RNA Capping and Decapping Enzyme”;
  • Yin Ruoyu, “The Use of Digital Mental Health and Wellbeing Tools in Older Adults: A Mixed Method Study”.

Our collaboration highlights a shared commitment to recognizing exceptional talent and research within the academic community, addressing today’s healthcare challenges, and inspiring continued innovation.

Looking Ahead to 2025

Building on the success of the first edition, MDPI and LKCMedicine are excited to announce that the 2025 MDPI Early Researcher Awards will continue to celebrate excellence and innovation in medical research. The next edition promises to expand its scope, introducing new categories and providing even greater recognition for impactful research.

Further details on the 2025 awards, including nomination criteria and timelines, will be shared in the coming months. We remain committed to fostering a culture of research excellence and collaboration within the global scientific community.

13 February 2025
MDPI Open Science Insights: Academic Publishing Workshop at the University of Manchester, 20 February 2025

MDPI is excited to collaborate with the University of Manchester, UK, to host an exclusive author workshop aimed at empowering researchers with the knowledge and tools needed for successful academic publishing. This workshop will delve into the key aspects of MDPI’s open access publishing framework, offering an in-depth exploration of journal selection, the editorial workflow, and the essentials of publication ethics. Participants will also gain practical advice on improving scientific writing and effectively addressing reviewer comments, with guidance from experienced professionals in the field. This session promises to equip attendees with valuable skills to elevate their publishing journey.

Date: 20 February 2025

Time: 11:00–13:00

Venue: 1st Floor Common Room, Stopford Building, University of Manchester, UK

Registration link: https://www.surveymonkey.com/r/ZQBVLG5

Schedule:

Speakers

Program and Content

Time

Mr. Norbert Eduard Kiss

Introduction of Session + Biomolecules Journal

11:00–11:10

Ms. Mary O’Sullivan

The Editorial Process, how to perform a peer review, and how to respond to peer review comments

11:10–11:55

 

Q&A Session

11:55–12:00

Ms. Rebekah Paget

Raw data usage, proper citations, and career opportunities in publishing

12:00–12:55

 

Q&A Session

12:55–13:00

Chair:

Name: Dr. Martin Baron

Affiliation: School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Michael Smith Building, Oxford Rd. Manchester M13 9PY, UK

Speakers:

Mr. Norbert Eduard Kiss obtained his B.Eng. in biotechnologies in 2019 and, shortly afterwards, joined MDPI as an Assistant Editor for Biomolecules. Later, he became a Section Managing Editor and a Group Leader. He is currently based in Cluj-Napoca, Romania, and works as a Journal Relations Specialist for Biomolecules and Geriatrics, primarily focusing on journal relations and publication ethics.
Ms. Mary O'Sullivan obtained her B.Sc. in genetics in 2019 and her M.Sc. in molecular cell biology with bio-innovation in 2020 from the University College Cork in Ireland. She started her career at MDPI in January 2023, working in the Editorial Department for the journal Cancers as an Assistant Editor and, following this, a Section Managing Editor. Currently, Ms. O'Sullivan is a Journal Relations Specialist based in the UK office in Manchester.
Ms. Rebekah Paget graduated from Newcastle University with an MChem in chemistry in 2020 and joined MDPI Manchester as an Assistant Editor for Materials in September 2021. She is currently a Journal Relations Specialist for the journals Materials, Alloys, and Optics.

5 February 2025
MDPI INSIGHTS: The CEO's Letter #20 - Beijing, Singapore, Bangkok, JAMS, Jisc

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2024 Annual Meeting – Beijing (15 January 2025)

You haven’t truly experienced a New Year’s celebration until you’ve attended one of MDPI’s Chinese Annual Meeting festivities. This year I visited our annual meeting in Beijing, held on the 15th of January.

Imagine this: stepping into a banquet hall filled with 140 tables and about 1,400 colleagues from our Beijing offices, all gathered to share in a six-hour event. The agenda included year-end speeches and presentations, a variety of performances by our colleagues, a selection of awards honouring local employees for their work, group photos for the memories, and a dinner.

This may have been one of the largest events I have attended. For those unaccustomed to such an event, it might seem overwhelming, but it was quite the opposite. The atmosphere was one of celebration as everyone came together to support their peers and celebrate the achievements of 2024.

I was honoured to deliver the opening speech and a presentation highlighting our growth and investment in MDPI’s most valuable asset: our people.

“Our editorial teams represent MDPI at its finest”

I want to give special recognition to the editorial department, across all of our offices, which forms the heart of our business. These teams are the frontline communicators with our authors, reviewers, and guest editors, creating a smooth experience of processing our manuscripts. Their professionalism and kindness are often highlighted as key drivers of satisfaction with MDPI. For this, I extend my deepest gratitude to all our editorial staff, across every office. They truly represent MDPI at its finest.

Beijing is home to two of our offices, with just over 800 employees in Tongzhou and over 600 in Haidian. Thank you to our administrative teams and everyone involved in organizing these New Year’s celebrations across all offices. These events provide a moment to reflect on our shared accomplishments and appreciate the positive impact each of you has on our culture.

MDPI Offices in China

While the history of MDPI begins in Basel, Switzerland, the story of MDPI is very much rooted in China. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

To date, over 381,000 MDPI research articles have been published by authors affiliated with Chinese institutions, making China our largest market. This is reflected not only in the volume of publications but also in the scale of our workforce supporting local operations and contributing to global success.

While no new offices in China were launched between 2022 and 2024 due to the pandemic and strategic planning, we remain committed to future growth here. Our plans include expanding operations as we continue to build our global workforce.

We look forward to a year filled with continued collaboration, growth, and shared success.

“We remain committed to future growth in China”

Impactful Research

MDPI and Jisc Consortium Extend Open Access Agreement for 2025

I’m pleased to share that MDPI has extended its agreement with the Jisc consortium in the UK for 2025. This renewal strengthens our partnership with UK institutions and reaffirms our shared commitment to advancing open access publishing.

Jisc is the UK’s not-for-profit digital, data, and technology agency supporting tertiary education, research, and innovation. Through initiatives such as our agreement, Jisc helps institutions access essential digital resources and infrastructure to support researchers. Currently, 62 UK institutions are part of our Institutional Open Access Program (IOAP) through this partnership.

Authors from participating institutions benefit from discounts on article processing charges (APCs), with even greater support for institutions that centrally fund APCs. This helps researchers focus on their work while simplifying the publishing process.

A full list of participating institutions can be found here.

As Becky Castellon, our Institutional Partnerships Manager, puts it: “Extending our agreement with Jisc is a reward for the strong partnership we’ve built with research institutions throughout the UK.”

At MDPI, we are dedicated to making research more accessible while reducing administrative burdens for institutions and authors. Open access publishing is at the heart of what we do, and we’re proud to expand its reach in the UK and beyond.

Inside MDPI

Visit to MDPI's Singapore office

During my January trip to some of our APAC offices, I also had the pleasure of visiting our Singapore office for the first time. It’s exciting to see how much the team has grown, now numbering over 55 staff members, with more joining us in February.

Welcoming and Supporting New Team Members

“Experienced staff play an important role in mentoring new hires”

I had the opportunity to connect with both experienced colleagues and new team members who are currently embarking on their careers. This visit reminded me of what it was like when I was in their shoes. I encourage all of us to engage new colleagues with empathy, as we have all been in their position. By creating a welcoming and supportive environment, we can help them settle in and learn about the corporate world, MDPI and our mission.

Experienced staff play an important role in mentoring and guiding new hires, most of whom are transitioning from academia to their first job. I’m especially grateful to colleagues such as Colin Chen, Alicia Ren, Yu Nwe Soe, Colin Wee, Amy Cham and other senior members who have contributed to shaping the culture and work environment in Singapore.

Building MDPI’s Positive Reputation

During my visit, I spoke with the office staff about the importance of their roles in building a positive reputation that helps create trust in MDPI. I shared how every interaction and communication point contributes to the marketing of MDPI and our journals. I also highlighted the career development opportunities available as MDPI continues to grow.

Connecting with the Singapore Marketing Team

I also spent time connecting directly with the Singapore Marketing team, which has quickly grown to 15 young and ambitious members. They are eager to learn and are actively contributing to our journal and corporate marketing activities. I shared insights into our corporate marketing structure and strategy and look forward to supporting them as they grow. 

During the visit, I was joined by my colleague Dr. Constanze Schelhorn, Head of Indexing, who provided training on indexing. This training was greatly appreciated by the local staff.

Meeting with Prof. Dr. Manoj Gupta

Lastly, we had the privilege of meeting Prof. Dr. Manoj Gupta, Editor-in-Chief (EiC) of Technologies since 2016 and Section EiC of Metals.

Prof. Gupta is an active decision-maker for the journal and a great brand ambassador for MDPI.

Prof. Gupta has helped sustainably scale Technologies, which now has a 4.2 Impact Factor and a 6.7 CiteScore, ranking Q1 in the JCR category of Engineering and Q1 in the CiteScore category of Computer Science.

During our meeting, we discussed strategies for Institutional Open Access Partnership agreements and ways to promote MDPI journals in Singapore.

PS. During the visit, we also had the chance to participate in Lo Hei, also known as Yee Sang or the “prosperity toss.” This is a raw fish salad traditionally enjoyed during Chinese New Year and is particularly popular among Chinese communities in Singapore, Malaysia, and Indonesia. Everyone gathers around the table as the ingredients are added one by one, and then the salad is mixed together. It was a fun experience to take part in this New Year tradition!

 

Coming Together for Science

JAMS – Journal & Article Management System

I am excited to announce the official relaunch of JAMS (Journal & Article Management System), one of MDPI’s key initiatives to support academic publishers worldwide.

With this relaunch, JAMS now offers new pricing models and flexible solutions for small-scale journals, commercial publishers, and university presses. We have also redesigned the JAMS website to enhance the user experience.

“JAMS is a testament to our commitment to simplifying the publishing process”

Explore the new website here: jams.pub

It’s also great to see the JAMS team expanding our presence at conferences and on social media to engage more effectively with the academic community.

Recently, Facundo Santomé (Senior Marketing Manager) and Alex Ramos (Senior Marketing Specialist) represented JAMS at the APE 2025 conference in Berlin, highlighting how our platform empowers small and independent publishers to streamline and scale their journal management.

JAMS was built to change that by adapting to the unique requirements of each publisher.

At MDPI, we continually invest in our growth – not only by expanding our operations and staff but also by developing innovative products that serve the academic and publishing community at large. JAMS, with its comprehensive suite of journal management tools, is a testament to our commitment to simplifying the publishing process for our partners.

Imagine a submission system that frees up your time for strategy, innovation, and impactful publishing.

Under the leadership of Silvano Bonfatti (Product Manager, MDPI), the JAMS team has conducted in-depth market research to understand the challenges publishers face: endless administrative tasks, inefficient workflows, and systems that don’t always meet their needs.

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

What Sets JAMS Apart?

  • Scalability – Whether you're a niche journal or managing thousands of submissions, JAMS grows with you.
  • End-to-End Workflow – From submission to peer review and final publication, everything is in one place.
  • Automation That Works for You – Say goodbye to chasing reviewers and formatting issues, so that you can focus on quality instead.
  • Built by Publishers, for Publishers – JAMS is backed by MDPI’s expertise; we know exactly what it takes to run a journal smoothly.
  • Flexible & Fair Pricing – Supporting journals of all sizes, with special rates for non-profits and publishers in the Global South.

Partners Who Already Trust JAMS

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

Closing Thoughts

Visit to MDPI's Bangkok office

To conclude my APAC trip, I had the pleasure of visiting our Bangkok office from 22 to 24 January. The office has grown significantly, closing 2024 with a total of 445 colleagues across various departments, including Editorial, Production, Conference, Training, Journal Relationship Specialists (JRS), Managing Editors, and supporting teams in HR, Admin, IT, and Finance.

I would like to praise our Bangkok management team for their excellent work in supporting our growth and creating a positive work environment. Our colleagues here are humble, talented, hardworking, and appreciative of MDPI’s mission.

Thailand was among MDPI’s top 30 markets in 2024 for total publications. With our office in Bangkok, we have an opportunity to further promote open access while supporting local researchers and institutions. This includes open access discounts, author training sessions, conference sponsorships, and other initiatives. We currently have 25 Editorial Board Members (EBMs) from Thailand and will work on expanding this network.

Engaging with Group Leads

“Group leads play an important role in creating a safe, positive environment”

During my visit, I met with our group leads to highlight their crucial role in managing journal performance and mentoring new employees, especially given our increased hiring targets. Many new hires are early in their careers and require training, development, and support. Group leads play an important role in creating a safe, positive environment that fosters professional growth while maintaining MDPI’s reputation for service quality.

To wrap up the session, I added a personal touch by holding the door and giving everyone high-fives – a small gesture to show appreciation, boost morale, and strengthen team spirit. It’s important for our colleagues to feel seen, heard, and valued.

University Visit: King Mongkut’s University of Technology North Bangkok (KMUTNB)

We also visited King Mongkut’s University of Technology North Bangkok (KMUTNB) to explore collaboration opportunities.

Our discussions focused on: Institutional Open Access Partnership (IOAP), Author training sessions, Conference sponsorships, Student employment initiatives, and more.

This visit reinforced the importance of building strong relationships with local universities, ensuring we continue to support and engage with the academic community in Thailand.

“My time in Bangkok was productive and inspiring”

My time in Bangkok was productive and inspiring. The senior team has done a great job in growing the office and creating a supportive, high-performing environment. I look forward to seeing continued success from our colleagues in Thailand.

Stefan Tochev
Chief Executive Officer
MDPI AG

4 February 2025
World Cancer Day 2025—United in Every Journey


Cancer impacts millions of lives worldwide, yet each person’s journey with the disease is uniquely their own. World Cancer Day reminds us that while the disease impacts individuals differently, our shared strength, innovation, and focus on holistic care bring us closer to a future where cancer no longer dictates lives. Every experience, challenge, and success story contribute to the broader fight against cancer, demonstrating the resilience and hope that unite us all. As we continue to make strides through innovative research, treatment advancements, and global collaboration, it is essential to recognize both the diversity of stories and our common goal of overcoming cancer together.

In observance of this day, we invite you to explore the following resources that delve into the field of cancer and the cutting-edge advancements shaping its care. By prioritizing people-centered treatment where patients’ voices and needs guide care, we can ensure personalized attention for all. It is our hope to foster a deeper understanding of the impact of cancer and encourage meaningful action to support patients, caregivers, and researchers in their pursuit of a world free from cancer’s hold. Together, we can inspire action and work toward a cancer-free future.

Biology & Life Sciences

Medicine & Pharmacology

Chemistry & Material Sciences

Public Health & Healthcare

Engineering

Society

Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54–62; https://doi.org/10.3390/dermatopathology10010008

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
by Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina et al.
Pharmaceuticals 2023, 16(2), 299; https://doi.org/10.3390/ph16020299

Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine
by Maurizio Cè, Giovanni Irmici, Chiara Foschini, Giulia Maria Danesini, Lydia Viviana Falsitta, Maria Lina Serio, Andrea Fontana, Carlo Martinenghi, Giancarlo Oliva and Michaela Cellina
Curr. Oncol. 2023, 30(3), 2673–2701; https://doi.org/10.3390/curroncol30030203

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by Onyinyechi Obidiro, Gantumur Battogtokh and Emmanuel O. Akala
Pharmaceutics 2023, 15(7), 1796; https://doi.org/10.3390/pharmaceutics15071796

Biomarkers in Breast Cancer: An Old Story with a New End
by Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, Matheus Correia Casotti, Diego do Prado Ventorim, Jucimara Ferreira Figueiredo Almeida, Valdemir Pereira de Sousa, Marllon Cindra Sant’Ana, Rahna Gonçalves Coutinho da Cruz, Luana Santos Louro et al.
Genes 2023, 14(7), 1364; https://doi.org/10.3390/genes14071364

Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
by Marin Golčić and Andrej Belančić
Diabetology 2023, 4(4), 553–559; https://doi.org/10.3390/diabetology4040049

Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers
by Ravi Bharadwaj, Swati Jaiswal, Erandi E. Velarde de la Cruz and Ritesh P. Thakare
Diseases 2024, 12(3), 63; https://doi.org/10.3390/diseases12030063

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
by Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki and Konstantinos G. Toutouzas
Curr. Issues Mol. Biol. 2024, 46(4), 2827–2844; https://doi.org/10.3390/cimb46040177

Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
by Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca and Mercedes Nadal-Serrano
Biology 2024, 13(5), 302; https://doi.org/10.3390/biology13050302

Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions
by Abdullah Younis and John Gribben
Immuno 2024, 4(3), 186–210; https://doi.org/10.3390/immuno4030013

Breast Cancer Screening among African Immigrants in the United States: An Integrative Review of Barriers, Facilitators, and Interventions
by Julian I. Rauch, Joseph Daniels, Alyssa Robillard and Rodney P. Joseph
Int. J. Environ. Res. Public Health 2024, 21(8), 1004; https://doi.org/10.3390/ijerph21081004

Predicting Leukoplakia and Oral Squamous Cell Carcinoma Using Interpretable Machine Learning: A Retrospective Analysis
by Salem Shamsul Alam, Saif Ahmed, Taseef Hasan Farook and James Dudley
Oral 2024, 4(3), 386–404; https://doi.org/10.3390/oral4030032

Comprehensive Treatment of Rectal Cancer

Mental Health and Nursing Care of Individuals with Cancer and Their Families—2nd Edition

New Advances in Community-Based Approaches to Cancer Prevention Epidemiology

Cancer Immunotherapy and the PD-1/PD-L1 Checkpoint Pathway

Novel, Low Cost Technologies for Cancer Diagnostics and Therapeutics

Metabolic Reprogramming in Cancer: New Frontiers for Therapeutic Intervention

Pulmonary Fibrosis and Lung Cancer: Pathophysiology and Novel Therapeutic Approaches

 

26 January 2025
Acknowledgment to the Reviewers of Biomolecules in 2024


The editorial team at Biomolecules extends our heartfelt thanks to the dedicated reviewers whose expertise and commitment have been key to the journal's success in 2024. Last year, Biomolecules received 7392 review reports from 4890 reviewers representing 86 countries and regions worldwide.

To recognize the invaluable time, effort, and attention to detail that each reviewer dedicates, Biomolecules expresses its sincere gratitude through an annual acknowledgment of reviewers. As a further token of appreciation, all reviewers are eligible for the Outstanding Reviewer Award, which honors their essential role in enhancing the quality of our publications.

We are honored to recognize the reviewers who allowed us to publish their names each year. The names of these reviewers are listed below in alphabetical order by first name:

A. N. M. Mamun-Or-Rashid Guangyan Wu Navaneet Chaturvedi
Abbirami Elangovan Guanying Li Nawal Kishore Khadka
Abdelaziz Amrani Guillaume E Courtoy Neil Sanford Greenspan
Abdelfattah A. Dababat Gundeep Kaur Nelly Georgieva
Abdelfattah El Moussaoui Gunnar Boysen Neluwa-Liyanage Ruwan Indika
Abdelnaser A. Elzaawely Gunnar Lars Olsson Nevena Milčić
Abdul Azeez Sayed Gunter Schmidtke Nicla Romano
Abeer M. M. Abdalhamed Gustavo Chaves Nicola Hamilton-Whitaker
Abhilash Jayaraj Guy Cohen Nicoletta Di Simone
Adnan Akhter Guzel Sharipova Nidhi Joshi
Adrian Florea Hadel Aboenin Nidula Mullappilly
Adrian Keller Haibo Liu Nik Tsotakos
Adriana Anita Haidi Karam-Allah Ramadan Niketa Patel
Adriana Hangan Haifei Shi Nikolaos Chrysanthakopoulos
Adriana Ribeiro Silva Haitao Wang Nikoleta Bizymi
Ahmad Elbahnsi Haitham Eldoumani Nikoletta Almási
Ahmed Ali Hajnalka Lőrincz Nilimesh Das
Ahmed M. Mostafa Hamdy Kashtoh Nils Von Neuhoff
Aidin Foroutan Hans Binder Nima Firouzeh
Aijaz Ahmad John Bhat Hans Degens Nina Filip
Aikaterini Theodorou Hans-Petter Hersleth Nina I. Kashchenko
Ajay Pal Hao Cao Ningning Wang
Aji Alex Moothedathu Raynold Hao Xing Niranjan Dodantenna
Ajmer Singh Grewal Hao Zang Noora Barzkar
Akhil Varshney Hao Zhang Nuno M. S. Almeida
Alberto Hidalgo-Bravo Harald Schulze Nunzia Limatola
Alberto Inga Harinarayanan Janakiraman Nurhan Keskin
Alberto Kousuke De La Herrán-Arita Harindranath Kadavath Oana Cioanca
Aldo Ferreira-Hermosillo Harish Sankarasubramanian Oleg Batishchev
Aldona Siennicka Hassan Mubarak Ishqi Oleg Demidov
Alejandro Castro-Alvarez Hassan Rasouli Olga L. Voronina
Aleksandar Ž. Kostić Hayato Ohshima Olga Lebedeva
Aleksandr Kruchinin He You Olga Protchenko
Aleksandr N. Ignatov Heba Abd Elghany Sahyon Olga Vadimovna Kurmyshkina
Aleksandra Pavićević Henry M. Staines Olga Vinogradova
Aleksandra Suchanecka Hin Hark Gan Olgica Nedic
Aleksandra Vilotić Hiroaki Yokota Olgica Stefanovic
Aleksey Zaitsev Hiroki Kittaka Oliver Gorka
Alessandra Piscitelli Hodaka Fujii Oliver Ozohanics
Alessandro Alaimo Ho-Jin Lee Omer Kacar
Alessandro Lavoro Hongcui Cao Otávio Augusto Chaves
Alessandro Maugeri Howard Schneider Ovidiu Pop
Alessandro Strumia Hridaya Shrestha Ovidiu-Cristian Oprea
Alessandro Tubita Huai Deng Pablo Mora-Ruiz
Alessio Noghero Huangen Ding Pablo Padilla-Iserte
Alexander Bartelt Hugo A. L. Filipe Pablo Sanchez-Quinteiro
Alexander Baykov Hugo Alexandre Oliveira Rocha Pádraic J. James Dunne
Alexander Buchberger Hugo Fraga Pal Perjesi
Alexander J. Bankovich Hugo Ramírez Álvarez Pallavi R. Devchand
Alexander J. Michels Hui Han Pamela Gehron Robey
Alexander Moskalensky Huiming Lu Panagiota Anyfanti
Alexandra Craciun Hui-Yun Cheng Panagiota S. Filippou
Alexandra Shintyapina Hung-Lin Chen Panagiotis Mallis
Alexandra Zakharenko Hunter Moseley Pandiyan Muthuramalingam
Alexandre Maréchal Hyun-Min Kim Paola Ungaro
Alexandre Vetcher Hyun-Woo Park Paolo Scrimin
Alexey A. Komissarov Ibrahim Gad Pasquale Marrazzo
Alexey Chubarov Ichwaku Rastogi Patrick D. Gajewski
Alexey Ivanov Igor Dovgal Paul Martin Harrison
Alexey Kostyukov Igor José Dos Santos Nascimento Paul S. Hoffman
Alexey Nikulin Igor Ovchinnikov Paulina Gil-Kulik
Alexey Sarapultsev Igor Slivac Paulina Gonzalez
Alexi Kiss Ildiko Szanto Paulo Augusto Netz
Alexia Kagiava Ilias Gkikas Paulo Euzebio Cabral Filho
Alfonso Baldi Ilya Fateev Paulo Zaini
Alfredo Cabrera-Orefice Ilya V. Ozhogin Pavel Marozik
Ali El-Raghi Iman Tavassoly Pawan Faris
Alice Mallia Inga Igorevna Poletaeva Pawan Kumar Raut
Alice Romeo Inmaculada Martín-Burriel Pedro Catalão Moura
Alicia M. Zelada Ioana C. Stănescu Pedro De Magalhães Padilha
Alicja Stachelska-Wierzchowska Ioana Dorina Vlaicu Pedro Lei
Alina Grigor'Eva Ioana Mozos Pedro Martín
Alina Serb (Georgescu) Ioannis Kyrou Pedro Martínez-Paz
Alireza Shoari Ira Jain Peli Foka
Allison B. Reiss Iraj Alipourfard Peng He
Almerinda Di Venere Irena Nalepa Pengfei Wang
Alvaro Compañ-Bertomeu Irene Buj-Corral Petar Ozretić
Amalendu Prakash Ranjan Irina Balan Peter J. Lyons
Amani Alghalayini Irina Kologrivova Peter Moore Macdonald
Amar Singh Irina Viktorovna Sukhovskaya Peter V. Dubovskii
Amarish Yadav Isabel Cardoso Petro E. Petrides
Amilcare Barca Isabel Marques Philippe Supiot
Amina L. Mohamed Isabel Soto-Cruz Pierre Tufféry
Aminallah Tahmasebi Isabelle Hue Ping Wang
Amit Manhas Itamar Luís Gonçalves Pingfan Hu
Amit Panwar Ivaldo Itabaiana Jr Polina M. Tyubaeva
Amit Sandhu Ivan Brukner Prabu Paramasivam
Amjad Islam Aqib Ivan Sabol Pratap Basim
Amr A. Arafat Ivana Perić Prathyusha Bagam
Amritlal Mandal J. Patrick O'Connor Praveen Koganti
Amy Pickering Jack Lawler Praveen Naik
Ana Budimir Jacqueline Phillips Pravin Hivare
Ana Catarina Sousa Jae-Heung Ko Preetha Rani Muthukrishnan Renuka
Ana Dobreva Jaekyung Shim Prithviraj Nandigrami
Ana I. Flores Jaggi Ujjaldeep Qi He
Ana Isabel Roca Fernández Jagmohan Hooda Qian Liu
Ana M. Gómez Jaime Delgado Qin Xiang Ng
Ana Paula Serafini Immich Jalil Ghassemi Nejad Qingjian Ou
Ana Rita Jesus James Arthur Maclean Qiu Li
Anamaria Apan Jamir Pitton Rissardo Qiushuang Wu
Ana-Maria Iordache Jan Bogacki R. M. Damian Holsinger
Anastasia Repouskou Jan Udala R. Steven Esworthy
Anastasia Sudarikova Janakiram Vangala Rabia Ayub
Anastassios Papageorgiou Jane Ratford Radosław Balwierz
Anca Stana Jaroslav Pavlů Radu Ciprian Racovita
Anca Toiu Javier Caballero-Villarraso Rafael Yutaka Kuradomi
Ancy Joseph Javier Murciano-Calles Rafaela Vasiliadou
Anđela Horvat Jayanta Kumar Patra Raffaele Pellegrino
Anderson Oliveira Souza Jean Amiral Raghu Ramanathan
Andras Garami Jean Sévigny Rahul K. Gupta
Andrea D'Arino Jean-Marie Exbrayat Rais Ansari
Andrea Deledda Jeffrey J. Destefano Rajesh Pamanji
Andrea Silvio Giordani Jelena Roganović Rajith Varman Seshappa Venkatesan
Andreas Brachner Jelena Skuljec Rakesh Arya
Andreas Breidbach Jennifer Gubitosa Ralf Henkel
Andreas Kyrozis Jennifer K. K. Spinler Ramachnadran Samivel
Andreas Vitsos Jennifer Stapleton-Kotloski Ramesh Prasad
Andrei Alexandrescu Jens Hahne Rami Salim Najjar
Andreia Rodrigues Jeongeun Hyeon Ramona Meanti
Andrew Amenaghawon Jeremy Alastair O'Sullivan Ranadheer Reddy Dande
Andrew Reynolds Jeremy Michael Van Raamsdonk Randi Hagerman
Andrey A. Mironov Jerome Carpenter Ranjeet Kumar
Andrey Elchaninov Jérôme D. Robin Ranka Godec
Andrey Marchev Jerzy Tadeusz Chudek Ravindra Thakkar
Andriy Khobta Jia Cai Raviraj Vankayala
Ángel Juan García Yagüe Jianlin Chu Rawil Fakhrullin
Angel Luis Ortega Jianyuan Chai Reik Loeser
Angeliki Magklara Jiawen Yong Remo Campiche
Angelo Naselli Jiawu Zhao Renata Ciccarelli
Angelos K. Sikalidis Jidan Ye Renata Cristina Mendes Ferreira
Anilkumar Thaghalli Shivanna Jie Liu Renata Duft
Aniruddha Das Jie Zhuang Renata Mikstacka
Anjan Motamarry Jimmy T. Efird Renata Teparić
Anna A. Brilkina Jin Zhang Renata Voltolini Velho
Anna B. Volnova Jing Liu Ren-Lei Ji
Anna Dembska Jingwei Mao Rex T. Nelson
Anna Koziorowska Jin-Hyuck Park Reza Assaran Darban
Anna Kusienicka Jinsai Shang Riccardo Leinardi
Anna M. Timofeeva Jiri Cerven Richard Galinier
Anna Makuch-Kocka Jitendra Kumar Richard Naftalin
Anna Olegovna Drobintseva Joachim M. Weitzel Rita Carmona
Anna Papadopoulou Joana Peixoto Ritika Gupta
Anna Sannino Joanna Bujak Rivka Ofir
Anna Sobiepanek Joanna Fiedor Robert Evan Hurst
Annakarina Mundorf João Martins De Mello Neto Robert F. Paulson
Anna-Mart Engelbrecht João Miguel Marques Dos Santos Robert Kuthan
Anne Kasus-Jacobi João Paulo Capela Robert Liefke
Annibale Antonioni Joaquim Carreras Robert Stryiński
Anthony Alfred Gaspari Joel Bornstein Robert Youker
Antionette Williams John Lalith Charles Richard Roberta Ricciarelli
Anton Pospelov John M. Chirgwin Roberta Zuntini
Antonella Antonelli John Parrish Roberto Eugenio Vogler
Antonello Mai John Voss Robin Cooper
Antonino Maniaci Jojo P. Joseph Rodney Bowden
Antonio Donaire Jolanta Dlugaszewska Rodolfo Reda
Antonio González-Sarrías Jolanta Natalia Latosińska Rodrigo Guarischi-Sousa
António Portugal Jolanta Orzelska-Gorka Roger Sm Chong
Antonio Ruiz-Gonzalez Jonathan Lindquist Rohit Kumar
Antonio Sanzo Jorg Bungert Roma Patel
Antonio Sermek Jörg Großhans Roman A. Sidorov
Antonio Yaghy Jörg Reichenwallner Roman Y. Medvedev
Anu Rani Jørn Bolstad Christensen Romana Marko Masnikosa
Anurag Misra Jose A. Morales-González Ronald Quinn
Arianna De Mori Jose Alberto Gallegos-Infante Ronald Sluyter
Ariel Teles Jose Antonio Poveda Larrosa Ronen Sumagin
Arlind Mara José Artur Brito Rong Ma
Armando Alexei Rodríguez Alfonso Jose Carlos Garcia-Borron Rosa Alba Sola-Martínez
Arthur M. Melkumyants Jose Cristobal Lopez Rosa Amoroso
Arun Kumar Rajendran José Luis Olivares-Romero Rosa Del Campo
Arvind Negi Jose M. Mulet Rosa Maria Vitale
Asdrubal Aguilera-Méndez José Peña-Amaro Rossella De Marco
Asim Abdulaziz Khogeer José Pérez Ruby Sharma
Assunta Pozzuoli José Rafael De Almeida Ruochuan Liu
Athanasia Mouzaki Jose Tudela Rupak Desai
Athanasios A. Panagiotopoulos Joseph Deweese Ruperto González-Pérez
Atiar Rahman Joseph E. Rupert Ruslan Kalendar
Attila Zsolnai Joshna Gadhavi Ryan Henry
Aviva Levina Joshua A. Bauer Ryan Michael Porter
Ayaz Ahmad Joshua Vorstenbosch Sabina Sevcikova
Ayrat U. Ziganshin Josipa Vlainić Sachin Chaugule
Ayush Vasant Ranawade Juan Carro Safa Faraj
Bac Viet Le Juan Jesus Perez Sahil Nalawade
Bahaa Jawad Juan Jose Acevedo Fernandez Saifei Lei
Balakumar Chandrasekaran Juan R. De Los Toyos Sajjad Hussain
Balraj Gopula Judge Xin Xu Salah A. Mohamed
Baltatu Madalina Simona Judit Oláh Salman Shahid
Barbara Hausott Judith-Irina Buchheim Salvatore Santamaria
Barbara Lovrecic Julia Nowowiejska Samara Eberlin
Bartłomiej Barczyński Julia Schumann Sandesh J. Marathe
Bartłomiej Potaniec Julianna Thuróczy Sandra Alicia Reza-López
Bartolo Ferraro Julio Camarero Sandra Del Moral-Ventura
Bartosz Sikora Julio Escribano Sandra Hirsch
Bassam Abusalama Elgamoudi Julio Plaza-Diaz Sanja Ivkovic
Beata Jabłońska Junhoe Kim Sanja Stankovic
Beatrice Severino Jun-Yi Zhu Sanjay Desai
Beatriz I. Fernandez-Gil Kai Yu Santiago Herrero
Belém Sampaio-Marques Kaimeng Huang Santidan Biswas
Bernard Leung Kaisong Yuan Sara Bonvini
Bi Chen Kaliannan Durairaj Sarah Tersey
Biagio Barone Kalyani Dhusia Sarath Babu Nukala
Bin Wang Kamil Haliloglu Sarthak Singhal
Binfeng Yin Kang Zhou Satish Kumar Sain
Birsen Yılmaz Kannan Sridharan Satomi Adegawa
Blanca Herrera Kaoru Tominaga Sauradip Chaudhuri
Bo Liu Karam El-Bayoumy Se Eun Ha
Boguslawa Luzak Karel Smetana Seema Singh
Bojidarka Ivanova Kari Stone Sekyoo Jeong
Boyan K. Garvalov Karolina Akinosoglou Sema Misir
Boyce Chang Karolina Bajdak-Rusinek Semer Maksoud
Bożena Nejman-Faleńczyk Karolina Gołąbek Sercan Karav
Braulio Marfil-Garza Kartik Bomb Serena Martinelli
Brian Andrews Karunakar Reddy Pothula Serge P. Bottari
Brian Michael Cartwright Katalin Sipos Sergey Ivanov
Bright Asare-Bediako Katerina Sazanova Sergey Sedykh
Brigitta Tóth Katrine M. Johannesen Sergey Tikhonenko
Brisamar Estébanez Kaustuv Basu Severina Semkova
Bruna Scaggiante Ke Cheng Shahrokh Paktinat
Burkhard Möller Keiichiro Suzuki Shantanu Gupta
Byung Seok Moon Ken Steven Rosenthal Shao Y. Lu
Byungyong Ahn Ken-Ichi Sato Shedeh Jodeh
Camelia Sorina Stancu Kenneth N. White Sheetalnath Babasaheb Rooge
Candice Mazewski Kenta Yamamoto Shehwaz Anwar
Cansu Ilke Kuru Kesen Ma Shenmin Zhu 
Carlo Santambrogio Ki Hyun Nam Shinichi Fukushige
Carlos Arterio Sorgi Kijin Kim Shinji Takamatsu
Carlos Corrêa-Netto Kinga Musiał Shira Roth
Carlos Rocha Oliveira Kirsten Scoggin Shivangi Rastogi
Carlos Rocha-De-Lossada Klaus Groschner Shizue Mito
Carlos Torres-Torres Ko Fujimori Shokrollah Elahi
Carlos Vicario Kohei Torikai Shou-Long Deng
Carly Filgueira Konda Kumara Swami Shounak Banerjee
Carmen Höglinger Konda Mani Saravanan Shuai Gao
Carmen Lopez-Sanchez Kossara Drenovska Shuai Wang
Carson Leung Kosuke Nishi Shubhra Jyoti Saha
Carsten Jaeger Kotchakorn T. Sriwong Shuya Kasai
Chandrasekhar Kottakota Kouji Hirota Shweta Pradip Jadhav
Chang Liu Krishna Kant Sijie Wang
Chao Ma Krishnendu Pal Silin Wu
Charles Viau Kristina Zlatina Silpa Gampala
Chen Zhou Krzysztof Dołowy Silvia Emilova Angelova
Cheng Chen Krzysztof Specjalski Silvia Hofer
Cheng Li Ksenia B. Tereshkina Silvia Rinaldi
Chenglong Yu Kshitiz Raj Shrestha Silvia Tampucci
Chenzhou Hao Kuan-Hui Ethan Chen Silvia Zorrilla
Chetna Tyagi Kun Lei Simon Galas
Chiara Foglieni Laima Blazyte-Cereskiene Simona Bernardi
Chika Saegusa Larisa Anghel Simona Cabib
Christian Lehmann Larisa Suturina Simona Dedoni
Christian Posbergh Lasse Lindahl Simona Saponara
Christian Rudolph Laura B. Payne Simote Foliaki
Christiane Branlant Laura Giannotti Sitansu Sekhar Nanda
Christina Pentari Laura Hughes Sivaraman Natarajan
Christine Yu-Nung Chuang Laurent Dubuquoy Sivasamy Sethupathy
Christoph Romanin Laurent Metzinger Siyan Cao
Chuanjin Wu Lawrence Mabasa Somdatta Bhattacharya
Chun Guo Le Li Somiranjan Ghosh
Cinta Zapater Leandro Castro Songli Zhu
Cinzia Fabrizi Lei Wang Sonia Aroni
Ciprian N. Silaghi Lei Yu Sonia Bailon-Ruiz
Clara Mariana Gonçalves Lima Leon Higley Sonia Do Carmo
Claudia Nioi Nioi Leopold Eckhart Sourav Roy
Claudia Segal-Kischinevzky Lexie Holliday Sridhar Selvaraj
Claudia Villicaña Liang Chen Srijit Das
Claudio De Felice Licínio Manco Srinivasu Karri
Claudiu C. Popescu Lilya U. Dzhemileva Sruti Bheri
Codrina Mihaela Ancuta Lin Huang Stanislav Naryzhny
Colin Gerard Egan Lin Li Stefan Acosta
Cong Gao Lin Ye Stefan Oliver
Cornelia Brunner Lingtian Zhang Stefania Brocca
Cosetta Ravelli Liqian Zhu Stefania Moscato
Cristian Bonvicini Liqing Zang Stefano Marullo
Cristian Mornos Lisa Kathleen Ryan Stefano Sol
Cristian Peptu Lisa Vinnedge Stelios Psarras
Cristian Sandoval Liudmila Lysenko Stepan Dzhimak
Cristina A. Ghiani Lokman Hossain Stephane Rety
Cristina Elena Zbârcea Lorena Duca Stephen J. Allen
Cristina Hebeda Lu Han Steven Michael Devine
Cristina Potrich Luca De Stefano Steven Singer
Cristina Sanchez De Diego Luca Ermini Stuart Lichtenberg
Cyrielle Billon Luca Simeoni Subba Rao Cheekatla
Daan Ren Lucia Rocco Subhadeep Das
Dalia Marija Kopustinskiene Lucía Téllez-Jurado Subhajit Chakraborty
Damiano Piovesan Luciana Bolsoni Lourenço Suchismita Roy
Daniel Dobslaw Luciana Teodora Rotaru Sudhir Kshirsagar
Daniel Florin Lighezan Lucinda Mcrobb Sudhir Kumar Rai
Daniel Guendel Ludger Hengst Sue Cotterill
Daniel Ricardo Delgado Luigi Donato Sueli Fumie Yamada-Ogatta
Daniel Sánchez De Alcázar Melendo Luigi Rosati Sujit Basak
Daniel Souza Monteiro De Araujo Luis B.P. Socas Sumeet Uday Nayak
Daniela Elena Serban Luis Diambra Sundararajan Jayaraman
Daniela Gabbia Luis Enrique Cobos Puc Susana Lechuga
Daniela Meleleo Luis M. Quirós Sushan Zhang
Daniela Novick Luisa Ricciardi Suvrajit Sengupta
Daniele Bani Lukasz Dobrek Sven Falke
Danilo Boskovic Lukasz Zdrojkowski Svetlana V. Guryanova
Danuta Jantas Luz Berenice López-Hernández Swanand Koli
Daria Pašalić Luz María Gonzalez Huerta Swapnil Singh
Dario Di Silvestre Luz Maria Rocha-Ramirez Swarbhanu Sarkar
Dario Estrin Luz Navarro Swati Garg
Dario Siniscalco Lyubov Getmantseva Syed Adeel Hasan
Dario Vrdoljak Lyudmila Asyakina Sylwia Grabska-Zielińska
Dariusz Nowicki M.Eduviges Burrola-Barraza Szilvia Kisvarga
Darlene Mitrano Ma Luo Tabussam Tufail
David A. Schwartz Ma. Cristina Romero-Rodríguez Tadanori Hamano
David Allan Butterfield Maciej Ugorski Tadayoshi Kagiya
David Centruion Madankumar Ghatge Takako Kaneko-Kawano
David Douches Madhusudhanarao Katiki Takayuki Nakagomi
David E. Levin Magdalena Machowska Takeshi Ohkubo
David Greenhalgh Magdalena Zabielska-Kaczorowska Talha Burak Alakus
David Haymer Magnus Monné Tamara Čačev
David Jarvis Magnus S. Ågren Tamás Arányi
David R. W. Hodgson Mahbub Mh Tânia S. Morais
David Sidney Leake Mahmoud Atya El-Meligy Tanja Grubić Kezele
David Snyder Mahmoud Kandeel Tanmay Kulkarni
Dawei Xue Maja Jazvinšćak Jembrek Tao Tao
Deborah Novelli Maja Lezaja Zebic Tao Wang
Deemah Dabbagh Małgorzata Duda Tao Wu
Deepranjan Sarkar Małgorzata Jarończyk Tapan A. Patel
Deepti Sharma Malgorzata Sierant Tapojyoti Das
Dejan Miloš Opsenica Manisha Jalan Tarana Arman
Dejan Stojkovic Manoj Kumar Pandey Taras P. Pasternak
Demetrios Arvanitis Mansoor-Ali Vaali-Mohammed Tatiana Kostrominova
Demitrios Vynios Maoshen Sun Tatiana V. Rakitina
Denglei Ma Mar Domingo Tatsuo Kido
Denis Corbeil Mara Gagliardi Tatyana Dyachkova
Denis Knyazev Marc Muller Tatyana Vlaykova
Denis V. Voronin Marc Surette Thelma Veronica Poggio
Denise Hemmings Marc Vasse Theo Kantidakis
Dennis R. Grayson Marcel H. M. Sari Theodoros Karalis
Désirée Gül Marcelo Nieto Thiebaud Picart
Despina Kalogianni Marcin Grąz Thierry Hauet
Despoina Pantazi Marcin Rozalski Thierry Magnaldo
De-Xin Kong Marco Aurelio M. Freire Thomas Dickmeis
Dhamodharan Prabhu Marco Diociaiuti Thomas Greither
Dhanaji M. Lade Marco Gerdol Thuluz Meza-Menchaca
Dhia Azzouz Marco Orlando Tigran Chalikian
Dhiraj D. Bhatia Marco Piccoli Tim Prickett
Dhivya Sridaran Marco Zeppieri Timothy Omara
Diana Torge Marek Orłowski Timothy R. Hoover
Diego Sauka Margarida Fonseca Cardoso Tom Levy
Dimitra Toubanaki Maria Anastasiou Tomás Rivas-García
Dinesh Barak Maria Antonietta Panaro Tomasz Gubica
Dipankar Ash Maria Cecilia Opazo Tomasz Powrózek
Dirlei Nico María Del Carmen Vargas-García Tomislav Bulum
Djemel Hamdane María Elena Estrada-Zúñiga Tomislav Tosti
Dmitri Kramerov Maria Elisa Drago-Serrano Tonali Blanco Ayala
Doletha Marian Szebenyi Maria Elisabetta Clementi Tong Wang
Domenico Pomarico Maria Golikova Torben Moos
Domenico Raimondo Maria Grigoriou Tsutomu Inoue
Dominik Dłuski Maria Iorizzi Tze-Sing Huang
Donghwa Kim Maria Jose Martinez Esteso Uener Kolukisaoglu
Dongzhu Duan Maria Malvina Tsamouri Ulises Hernández
Dorota Formanowicz Maria Morello Ursula Panzner
Duo Zhang Maria P. Monsalve Pérez Utibe-Abasi S. Udoh
Dusan Mladenovic Maria Saiz Vadim Genkel
Ebaston Thankarajan Maria Samara Vaitsa Giannouli
Edgar De Almeida María Teresa Hernández-Huerta Valber De Albuquerque Pedrosa
Edgar López López Maria Trovato Valentin Coppola
Ehab Hafiz Maria Victoria Sanchez Valentin Oleynikov
Ehsan H. Abu-Zeid Maria Vliora Valentina Valentina Chiodi
Eiichi Kumamoto Maria Zoumpanioti Valentina Vellecco
Eiichiro Nagata María-José Argente Valentine Bouet
Eisuke Amiya Marianna Flora Tomasello Valeria Di Dato
Ekaterina E. Khramtsova Mariano Andrea Scorciapino Valeria Manganelli
Ekaterina F. Kolesanova Marija Pinterić Valerie Petegnief
Ekaterina Lesovaya Marija S. Milic Valeriia Vasileva
Ekaterina Silina Marijn M. Speeckaert Valerio Leoni
Ekaterina Yu. Fedotova Marina Bouche Vanessa Bergamin Boralli Marques
Ekino Keisuke Marina Stavrou Vasiliy V. Pavlichenko
Elaine Dunlop Mario Alberto Ynga Durand Veera Chandra Sekhar Reddy Chittepu
Eleanor Lederer Mario Fruschelli Venkatesh Yarra
Elena G. Varlamova Mario I. Vega Vera A. Alferova
Eleni Karligiotou Mario Salazar-Páramo Vera Borzova
Eleni Mavrogonatou Mario Valentino Victor Meseguer
Eleonora Lai Mariya Alexandrovna Smetanina Victor Seledtsov
Eleuterio A. Sánchez Romero Mark Eiteman Vincenzo Zammuto
Eliane Silva Mark I. Evans Vinícius Augusto Simão
Elisa Belluzzi Marta Hałas-Wiśniewska Vinicius J. S. Osterne
Elisa Cairrao Martha Rocio Moreno Jimenez Vinod Nadella
Elisabeth Egholm Jacobsen Martin Modriansky Violeta Igna
Elisabetta Ferrara Martin Pejchinovski Visnja Lezaic
Elisabetta Genovese Martin Raspor Vita Sterna
Elisavet Vasilopoulou Martina Kropp Vito Calderone
Elizabeth Lewkowicz Martina Torricelli Vittoria Petruzzella Petruzzella
Elizabeth Vafiadaki Martine Tarsitano Vittorio Gentile
Emerson Soares Bernardes Mary Fafutis-Morris Vladimir Bojinov Bojinov
Emilia Lecuona Mary Taub Vladimir E. Silantev
Emily Sontag Maryna Stasevych Vladimir Korshun
Endre Czeiter Masafumi Muratani Vladlen Klochkov
Enikő Balogh Masahiko Tanaka Vlasios Karageorgos
Enrico Gallo Masanori Hijioka Vusal Aliyev
Enrique Castano Mashooq A. Bhat Wafaa Abd El-Ghany
Enzo Martegani Massimiliano F. Peana Walther Bild
Eric Ramirez Massimiliano Meli Waseem Jerjes
Erika Staudacher Massimo Tusconi Wei Guo
Erin Damsteegt Massimo Venditti Wei Shao
Erin Reed-Geaghan Matheus Azambuja Wei Wang
Estanis Navarro Matheus Vernet Machado Bressan Wilke Weihua Huang
Etelka Chung Matias Mosqueira Wei-Sheng Lin
Eugenio Velasco-Ortega Matteo Della Porta Weisheng Lu
Eva Martínez Pinilla Matteo Di Segni Weiwei He
Eva Torres Sangiao Matteo Sorge Wenchao Xu
Everardo López-Romero Matthew Merski Wenjing Yu
Evert Van Schothorst Matthias Eckhardt Wen-Li Hsu
Evgenia Korzhikova-Vlakh Mattia Paratore Wenlong Zhao
Evgeniya Vladislavovna Pushchina Mauro Lago-Docampo Wen-Ta Su
Ewelina Pałkowska-Goździk Maxime Cahuzac Wenwen Jing
Fabiano Vieira Vilhena Mayank Gautam Wenxuan Zhang
Fabrizio De Luca Md Abdul Hakim Wesley M. Raup-Konsavage
Fabrizio Gentile Mehdi Sanati Whidul Hasan
Fahad S. Alshehri Meihui Wu Wieslawa Lesniak
Faisal A. Alzahrani Melanie Markmann Wilfried Kues
Fan Xuan Melissa S. Totten William B. B. Rizzo
Fang Tong Melville B. Vaughan William Miller, Jr.
Fanny Legrand Menelaos Zafrakas William T. Heller
Farooq Riaz Meng Wu Winfried Weissenhorn
Federica Armeli Mercedes Lopez-Santalla Wing Shing Ho
Federico Castro-Munozledo Mercedes Lovrecic Wojciech Pietruś
Federico Zappaterra Merve Kulbay Wolfram Kunz
Felipe Vázquez-Flota Michael A. Babich Xavier Gallart-Palau
Felix Nitschke Michael Blumer Xia Xin
Félix Tomi Michael Mcmurray Xiao Ding
Fengyang Huang Michael Schäferling Xiaofei Wang
Ferenc A. Antoni Michael Van Dyke Xiaoguang Liu
Fernanda Cortez Lopes Michaela Patila Xiaokang Wu
Fernando Cardona Michail Nomikos Xiaolin Nan
Finlay Macrae Michela Milani Xin Bi
Fortunato Lonardo Michelangelo Luciani Xinru Qiu
Fotios Tsopelas Michele Galluccio Xinrui Gui
Francesca Pacifici Mihaela Adela Iancu Xiuli Li
Francesca Silvagno Mihaela Ionica Xolani H. Makhoba
Francesco Boccalatte Mihaela Niculae Xuejun Li
Francesco Trotta Mihaela Violeta Ghica Xuhui Zheng
Francisca Salas-Pérez Mihai Caramihai Yan Yang
Francisco J. Romero Mihail Mitov Yancheng Du
Francisco José Navarro-Triviño Mihaly Mezei Yang Yang
Francisco Lázaro-Diéguez Mikko Uusi-Oukari Yannis Karamanos
Francisco M. Nadal-Nicolas Milan D. Perovic Yaoxiang Li
Francisco Pinto Milan Houška Yashika Awasthi
Francisco Quereda Milena Tzanova Yashika Rustagi
Francisco R. Nieto Milena Veskovic Ye Gao
François Dragon Milica Aćimović Yegor Yegorov
Frane Paic Milica Pešić Yen-Sung Huang
Frank A. E. Kruyt Milka Mileva Yi Wang
Frank A. Simmen Ming Gao Yiannis Sarigiannis
Frank Erdmann Ming Zheng Yi-Chiang Hsu
Frank Richard Schubert Minu Chaudhuri Yi-Fan Tao
Franz Bracher Mirek Dundr Yik-Ling Chew
Frederick H. Silver Miriam A. Hickey Yin Qian
Frederico Omar Gleber-Netto Mirolyuba Simeonova Ilieva Ying Li
Fubiao Shi Miroslav Nenov Yingxue Zhang
Fulin Ma Miroslaw Kornek Yi-Qing Yang
Gabriel Gutiérrez-Ospina Miruna Micheu Yixin Chloe Xie
Gabriel López-Velázquez Mohamed A. A. Abdelhamid Yngve Stenstrøm
Gabriella Leonarduzzi Mohamed F. Zayed Yogesh Narkhede
Gabriella Morini Mohamed Hussein Hamdy Roby Yoichi Kobayashi
Gaëlle Lenglet Mohamed Jawed Ahsan Yong-Xin Liu
Galina Sergeevna Zakharova Mohamed Sharaf Yordan Muhovski
Ganesh Sable Mohammed M. Alanazi Yoshiaki Tsuji
Gang Du Mohammed Sikander Yoshinao Katsu
Gavin Stewart Mohd. Kamran Khan Yoshinari Uehara
Genki Terashi Mohsin Jafri Yoshinobu Kariya
George Grant Mònica Aguilera Yoshiro Horai
George Mihai Nitulescu Mónica Alexandra Teotónio Fernandes Youhei Hiromori
George Paraskevas Mônica Cassel Yousi Fu
Georges Maestroni Monica Trif Yu-Feng Xie
Georgiana Bianca Constantin Moumita Datta Yuh-Yih Lin
Georgios Iatrakis Mounica Bandela Yukihiro Okamoto
Georgios Pampalakis Muhammad Fasih Khalid Yulia S. Kudyakova
Gerald Audette Muhammad Imran Sajid Yung-Hsiang Chen
Gerald S. Manning Muhammad Riaz Yunting Zhu
Germán Domínguez-Vías Mukul Kumar Yuqi Yang
Gerrit Begemann Murali Palangat Yuri Shatalin
Gertrude-Emilia Costin Murat Basar Yuriy L. Orlov
Giacomo Lazzarino Murat Onur Yazlık Yuwen Dong
Gian Mario Migliaccio Myron Christodoulides Yuya Kumagai
Gil Alfonso Magos-Guerrero Myron R. Szewczuk Zachery Robert Gregorich
Gil Fraqueza Nadav Elad Zahra Khosrowpour
Giorgio Mangino Nafisa Gull Zehra Serap Arici
Giorgio Rispoli Nagesh Kishan Panchal Zhan Shu
Giovanni Cimmino Nagy Khalifa Zhenning Ren
Giovanni La Penna Nahid Khan Zhi Chao
Giovanni Levi Namrata Anand Zhide Ding
Giuliano Ciarimboli Nancy Oguiura Zhidong Zhou
Giuliano Tocci Nandini Kundu Zhifeng Xu
Giuseppe Bruschetta Naoyuki Sakamoto Zhijie Qi
Giuseppe Liberatore Narimane Segueni Zhiwei Yang
Giuseppe Miceli Narsimha Mamidi Zhi-Wen Hu
Giuseppe Murdaca Natale Calomino Zhiyong Ni
Gleb E. Aktuganov Natalia Kamanina Zining Lei
Gourav Chandan Natalia Sharova Zoran Minic
Graça Soveral Natalie Zingra Mary Homer Zoya Ignatova
Gregory Peterson Natalya S. Zinkevich Zsofia Edit Papay
Grzegorz Zieliński Nathalie Lalevée Zsuzsanna Mihály
Guangning Zong    

21 January 2025
MDPI’s Newly Launched Journals in December 2024

Nine new journals covering multiple subjects launched their inaugural issues in December 2024. We are excited to be able to share with you the newest research rooted in the value of open access.

We would like to express our deepest appreciation to all of the Editorial Board Members, and each journal will ensure its high-quality output by using excellent editorial and rigorous peer-review processes, to ensure that the articles achieve high impact and visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal Topics (Selected)


Prof. Dr. Zhaoyang Dong
City University of Hong Kong, China
Editorial | View inaugural issue

energy storage technologies; energy storage system management; energy storage applications; strategies in renewable energy generation grid integration; distributed storage systems; economics and markets for energy storage
View journal scope | Submit an article

Prof. Dr. Yang-Hui He
1. London Institute for Mathematical Sciences, Royal Institution, UK
2. University of Oxford, UK
Editorial | View inaugural issue
Euclidean geometry; differential geometry; algebraic geometry; complex geometry; discrete geometry; computational geometry; geometric group theory;  convex geometry
View journal scope | Submit an article

Dr. Michel Planat
Université de Franche-Comté, France
Editorial | View inaugural issue
differential topology; algebraic topology; manifold topology; homology theory; low-dimensional topology; fuzzy sets
View journal scope | Submit an article

Prof. Dr. Rashid Al Abri
1. Sultan Qaboos University, Oman
2. Oman Medical Association, Oman
Editorial | View inaugural issue
clinical practices as well as research and innovation in medical education, risk management in healthcare, and patient safety
View journal scope | Submit an article

Prof. Dr. Ecevit Bilgili*
New Jersey Institute of Technology, USA
*Prof. Dr. Ecevit Bilgili passed away before the completion of the inaugural issue. His dedication and vision for JPBI will always be remembered and serve as a guiding inspiration.
Editorial | View inaugural issue
early drug discovery and development; product characterization and pre-clinical testing; drug delivery systems and drug design; active pharmaceutical ingredient (API) production
View journal scope | Submit an article

Dr. Weiyong Liu
Huazhong University of Science and Technology, China
Editorial | View inaugural issue
theories, methodologies, technologies, and applications in the fields of laboratory medicine and clinical chemistry
View journal scope | Submit an article

Prof. Dr. Manuel Pedro Rodríguez Bolívar
University of Granada, Spain
Editorial | View inaugural issue
scientometrics; informetrics; bibliometrics; altmetrics; webometrics; research evaluation
View journal scope | Submit an article

Prof. Dr. Fei Fan
Wuhan University, Wuhan 430072, China
Editorial | View inaugural issue
regional growth theory and methods; regional system modeling and optimization; regional development policy; regional spatial evolution; environmental policy and instrument choice
View journal scope | Submit an article

Dr. Kevin Cianfaglione
Université Catholique de Lille, France
Editorial | View inaugural issue
wild species and their habitats; wild environments and biodiversity; natural environment management; wild land preservation
View journal scope | Submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflecting on 2024: Celebrating Our Progress and People

As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.

Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.

Looking for a new role in 2025? We have a variety of roles currently open!

Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.

These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.

On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.

Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.

“MDPI thrives because of community and collaboration”

When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.

As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.

Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.

PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.

Impactful Research

685 MDPI Editors Named Highly Cited Researchers in 2024

I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.

Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.

Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.

As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.

I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.

Inside MDPI

How MDPI / Open Access Supports Societies

MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.

Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.

Learn about how MDPI / Open Access Supports Societies.

In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.

If you would like to learn more about these services, please see the Societies website.

The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.

How long have you been at MDPI, and what was your first role?

I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team. 

Do you think that perceptions of Open Access are generally accurate?

Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards. 

How long have you been at MDPI, and what was your first role?

I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.

What is the most common question you get asked about the services that the Societies team provides?

For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.  

For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.

Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.

Read more:

Coming Together for Science

2024 MDPI Conference Summary

Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.

The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.

2024 Event Highlights

Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.

Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’

Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’

A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.

The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.

The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.

ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.

The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.

Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.

In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.

The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.

Scheduled Events in 2025

Closing Thoughts

Over 100 German Universities Partner with MDPI in New National Agreement  

I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.

This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.

Learn more, here.

“Thank you to everyone who contributed to making this agreement a reality.”

Why is this important?

Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.

This agreement reflects our growing influence and leadership in open access publishing.

Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.

As Peter Roth, MDPI Head of Publishing, noted:

“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.” 

Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:

“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform” 

Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.

Stefan Tochev
Chief Executive Officer
MDPI AG

20 December 2024
Biomolecules | Interview with Prof. Dr. Benoit Coulombe, Section Editor-in-Chief of Section “Biomacromolecules: Proteins”

We reached out to Prof. Dr. Benoit Coulombe, Editor-in-Chief of the Section “Biomacromolecules: Proteins”, to hear his thoughts on this year’s Nobel Prize and its impact on the scientific community and the publishing landscape.

Half of the 2024 Nobel Prize in chemistry was awarded to Demis Hassabis and John Jumper for their work on protein structure prediction, mainly through the development of the software AlphaFold. The other half of the prize was awarded to David Baker for his computational protein design work.

1. How do you see the 2024 Nobel Prize in chemistry, awarded for advances in AlphaFold's protein structure prediction, impacting the field of protein research?
It is rather rare that a Nobel Prize is awarded only a few years after a discovery or invention has been made. The first version of the software AlphaFold was launched in 2018, and the Nobel was awarded only 6 years later in 2024. In my opinion, this short “incubation period” demonstrates the importance of AlphaFold. This adds to the fact that the main Nature paper describing AlphaFold has been cited more than 20,000 times.

2. What are the current limitations of this discovery, and what improvements do you anticipate in the coming years?
Since the launch of the first version, two additional versions have been created. AlphaFold 2 in 2020 and AlphaFold 3 in 2024. The design of AlphaFold 2 is significantly different from AlphaFold 1 and the database is much larger, allowing a clear gain in performance. AlphaFold 3 is not limited to single chain proteins but can also predict the structure of protein complexes associated with RNA, DNA, ligands, ions and post-translational modifications (PTMs). In both cases, we witnessed important improvements. There is no doubt that additional improvements will be integrated in the coming years, paralleling the increasing power of computers. For example, AlphaFold protein modeling does not include most post-translational modifications, and its modeling of mutations is not yet robust. These points can be improved.

3. What are some of the most exciting recent developments in protein science that you believe deserve more attention?
Improvement in protein structure prediction, through AlphaFold, represents a quantum leap in protein science. Previous structure prediction software was largely inferior and the winning performance of AlphaFold at the competition Critical Assessment of Techniques for Protein Structure Prediction (CASP) is a reflection of this. Another aspect of protein science that deserves attention is Single-Cell Proteomics as this method allows us to illuminate the cell heterogeneity that takes place in organs and tissues, which has an important regulatory function. New generation mass spectrometers from different vendors will greatly accelerate Single-Cell Proteomics’ development.

4. As a Section Editor-in-Chief, how do you plan to shape “Biomacromolecules: Proteins” Section to include more research related to AI-based protein structure prediction?
As the development of AI tools progressively revolutionizes protein science, these tools will also reshape the Section “Biomacromolecules: Proteins”. I suppose this will be the case for other high-end journals. I predict that papers combining single-cell proteomics and AI will be more frequent in the coming years, leading to major advances in protein science.

5. Can you share any upcoming Special Issues or initiatives in the Biomolecules journal that focus on protein research and why authors should submit their work here?
We work hard to keep Biomolecules at the leading edge of research dealing with proteins with various initiatives such as Special Issues and thematic meetings. This is a good reason for researchers to submit their papers to Biomolecules.

17 December 2024
Over 100 German Universities Partner with MDPI in New National Agreement


More than 100 German universities and research institutions have entered into a national agreement with MDPI. The publication agreement negotiated by ZB MED comes into effect on 1 January 2025 and is valid until the end of 2026. Joining the consortium is still possible until the beginning of 2025. We are delighted by the high level of interest this agreement has already garnered, reflecting the strong demand for accessible and cost-effective open access publishing solutions among German research institutions.

This new cooperation aims to make scientific gold open access publishing more affordable and less administratively burdensome for researchers in Germany. The agreement includes substantial discounts on article processing charges (APCs) for corresponding authors from participating institutions. It offers flexible payment options, including centralized invoicing or individual payment of fees by researchers or their institutions. Additionally, the agreement features a flat-fee model that enables institutions to precisely plan expenses and optimize their library budgets.

"MDPI can look back on over a decade of successful partnerships with German research institutions," says Peter Roth, MDPI Head of Publishing. "The new agreement marks another milestone in the long-standing co-operation between MDPI and the German scientific community. It emphasizes our commitment to developing up-to-date and inventive solutions for the diverse needs of scientific institutions to promote open research for the benefit of researchers."

Petra Labriga, Head of Strategic License Management at ZB MED, highlighted the agreement's significance: "As one of the world's leading Gold OA publishers, MDPI plays a central role in the German publishing landscape. We are particularly pleased that we were able to achieve considerable potential cost savings for scientific institutions and their authors at a national level through our negotiations."

The partnership reflects a common goal of advancing the idea of open access and supporting researchers in making their scientific excellence internationally visible.

"We would like to thank the ZB MED consortium team for their excellent collaboration," added Adrian Stefan Zamfir, MDPI Institutional Partnership Manager for the DACH region. "We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform."

Franziska Fischer (right), Commercial Director at ZB MED, an Peter Roth (left), Head of Publishing at MDPI, celebrate the signing of the new national open access agreement between MDPI and the ZB MED Consortium.

Peter Roth (center) joined ZB MED's Lea Carolina Schindler, Petra Labriga, Franziska Fischer, and Jonathan Lehmann in Cologne, Germany, on 13 December 2024 to sign the agreement.

More Information

  • Conditions and participation opportunities (German): Link
  • Frequently asked questions (German): Link

Contact


About ZB MED

ZB MED - Information Centre for Life Sciences is an infrastructure and research centre for life science information and data. Its aim is to support and strengthen research for people and the environment: from medicine to biodiversity and environmental protection.

The work of ZB MED is orientated towards the strategic guidelines:

  • Research + Networking: We conduct research together with the regionally, nationally, European and globally networked research community.
  • Data science: We enable data analyses and generate new knowledge through research.
  • Access to information: We provide sustainable access to information, literature and data as a central information infrastructure.
  • Open + FAIR: We promote open and reproducible science in line with open science and FAIR principles.
  • Knowledge and skills transfer: We actively impart knowledge, competences and skills.

More information at www.zbmed.de.

About MDPI

Headquartered in Basel, Switzerland, MDPI is one of the world's leading open access publishers with a current portfolio of more than 440 journals in all scientific disciplines. MDPI‘s goal is to advance open science worldwide through greater transparency, efficiency and collaboration. To date, more than 3.7 million researchers have published their results in MDPI journals. The editorial process is overseen by a large network of dedicated reviewers and editors and supported by more than 6500 MDPI employees. MDPI currently works with over 800 academic institutions and 180 scientific societies worldwide, which benefit from a wide range of MDPI services and products.

17 December 2024
Article Layout and Template Revised for Future Volumes

We are pleased to announce a series of updates to our template, aimed at improving the readability and overall aesthetics of our publications. These changes have been meticulously designed to enhance the user experience and ensure consistency across all our publications. The updated template will be available for download from the Instructions for Authors page.

The following updates will be applied to articles published in the 2025 volumes, starting on 24 December 2024:

  • Main text: The line spacing has been increased to improve the readability of publications;
  • Header and footer: The link to the journal website will be removed, as a hyperlink has been integrated into the journal logo. Additionally, the DOI link will be moved from the left-hand side to the right-hand side, and both the header and footer will be slightly raised to achieve a better balance;
  • Left information bar: The information provided here has been rearranged for better organization; the CC-BY logo will be removed;
  • Font size: The font size used for the abstract, keywords, and first-level headings will be increased.

Furthermore, MDPI journals will continue to use article numbers. This approach enables us to maintain a rapid and efficient production process by being able to define pagination as soon as a paper is accepted.

We hope that the new version of the template will provide users with a better experience and make the process more convenient.

Please contact production@mdpi.com if you have any questions or suggestions.

Back to TopTop